Systems and methods for managing atrial-ventricular delay adjustments

US11654288B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11654288-B2
Application numberUS-202016988821-A
CountryUS
Kind codeB2
Filing dateAug 10, 2020
Priority dateAug 10, 2020
Publication dateMay 23, 2023
Grant dateMay 23, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A system and method are provided for managing atrial-ventricular (AV) delay adjustments. An AV interval is measured that corresponds to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event. A candidate AV delay is set based on the AV interval and a bundle branch adjustment (BBA) value. A QRS characteristic of interest (COI) is measured while utilizing the candidate AV delay in connection with delivering a pacing therapy. The BBA value is adjusted and the candidate AV delay is reset based on the BBA value as adjusted. A collection of QRS COIs and corresponding candidate AV delays are obtained and one of the candidate AV delays is selected as a BBA AV delay. The pacing therapy is managed, based on the BBA AV delay.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for managing atrial-ventricular (AV) delay adjustments, the system comprising: an implantable medical device (IMD) having a header that includes a right atrial (RA) header port, a right ventricular (RV) header port and a left ventricular (LV) header port; a first lead having a first electrode configured to be located proximate to an atrial (A) site, the first lead having a proximal end with a first lead terminal connected to the RA header port; and a second lead having a second electrode configured to be located proximate to at least one of a left bundle branch (LBB) site or a HIS bundle, the second lead having a proximal end with a second lead terminal connected to the RV or LV header port, memory configured to store program instructions; one or more processors that, when configured to execute the program instructions: measure an AV interval corresponding to an interval between Lan atrial paced (Ap) event or an atrial sensed (As) event, paced or sensed at the first electrode, and La sensed ventricular (Vs) event sensed at the second electrode; set a candidate AV delay based on the AV interval and based on a bundle branch adjustment (BBA) value, wherein the BBA value represents an adjustment to the AV interval to account for sensing the Vs event at the second electrode which is located proximate to at least one of the LBB site or the HIS bundle but connected to the RV or LV header port; measure a QRS characteristic of interest (COI) while utilizing the candidate AV delay in connection with delivering a pacing therapy by the IMD; adjust the BBA value and reset the candidate AV delay based on the AV interval and the BBA value as adjusted; repeat the adjust, reset and measure to obtain a collection of QRS COIs and corresponding candidate AV delays; select one of the candidate AV delays, that corresponds to a select one of the QRS COIs, as a BBA AV delay; and manage the pacing therapy, utilized by the IMD, based on the BBA AV delay. 2. The system of claim 1 , wherein the one or more processors are configured, when executing the program instructions, to implement, as the pacing therapy, a DDD mode pacing therapy, wherein the second electrode represents an LBB electrode configured to be implanted through a septal wall to a depth sufficient to be located proximate to the LBB site, the second lead terminal configured to connect the LBB electrode to the RV header port; and the IMD further comprising sensing circuitry configured to sense cardiac activity (CA) signals over an RV sensing channel, associated with the RV header port, wherein the CA signals are collected along a sensing vector defined at least in part by the LBB electrode, wherein the measure, adjust, repeat and select operations are based in part on the CA signals. 3. The system of claim 1 , wherein the one or more processors are further configured to select the one of the candidate AV delays that manages delivery of pacing pulses at the LBB site at a select point in time before an intrinsic wave front is expected to propagate to or beyond a corresponding point along a right bundle branch. 4. The system of claim 1 , wherein the one or more processors are further configured to select the one of the candidate AV delays that resulted in a narrowest QRS duration within the collection of QRS COIs. 5. The system of claim 1 , wherein the one or more processors are further configured to repeatedly adjust the candidate AV delay by subtracting, from the AV interval, multiple candidate BBA values in order to time delivery of pacing pulses at the LBB site at a point in time fused with intrinsic waveform propagation to or beyond a corresponding point along a right bundle branch. 6. The system of claim 1 , wherein the second electrode represents an LBB electrode configured to be implanted through a septal wall to a depth sufficient to be located proximate to the LBB site, the second lead terminal configured to connect the LBB electrode to the LV header port, wherein the pacing therapy corresponds to a cardiac resynchronization therapy (CRT) pacing therapy configured to deliver pacing pulses through the LV header port of the IMD to the LBB electrode. 7. The system of claim 6 , wherein the one or more processors are further configured to select the one of the candidate AV delays that manages delivery of pacing pulses at the LBB site at a select point in time after an intrinsic wave front is expected to propagate to or beyond a corresponding point along a right bundle branch. 8. The system of claim 1 , wherein the second electrode represents a load including a HIS electrode configured to be located at the HIS bundle, the lead including a proximal terminal configured to connect the HIS electrode to the RV header port; the IMD further comprising: sensing circuit configured to sense cardiac activity (CA) signals over an RV sensing channel associated with the RV header port, wherein the CA signals are collected along a sensing vector defined at least in part by the HIS electrode, the candidate AV delays and BBA AV delays following a new As or Ap event before a pacing stimulus is delivered through the RV header port to the HIS bundle. 9. The system of claim 1 , wherein the BBA value provides an adjustment to the AV interval to account for the Vs event being sensed at the second electrode when connected to the RV header port and located proximate to at least one of the LBB site or the HIS bundle. 10. The system of claim 1 , wherein the BBA value provides an adjustment to the AV interval to account for the Vs event being sensed at the second electrode when configured to be located proximate to the LBB site and the second lead terminal is connected to the RV header port. 11. The system of claim 1 , wherein the second electrode is configured to be located proximate to the HIS bundle and the second lead terminal is connected to the RV header port, the system further comprising a third lead having a third electrode configured to be located proximate to the LV and having a third lead terminal connected to the LV header port. 12. The system of claim 1 , wherein the second electrode is configured to be located proximate to the HIS bundle and the second lead terminal is connected to the LV header port, the system further comprising a third lead having a third electrode configured to be located proximate to a right ventricular (RV) apex and having a third lead terminal connected to the RV header port. 13. A system for managing atrial-ventricular (AV) delay adjustments, the system comprising: electrodes configured to be located proximate to an atrial (A) site and at least one of a left bundle branch (LBB) site or a HIS bundle; an implantable medical device (IMD) having a header that includes a right atrial (RA) header port, a right ventricular (RV) header port and a left ventricular (LV) header port; memory configured to store program instructions; one or more processors that, when configured to execute the program instructions: measure an AV interval corresponding to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event; set a candidate AV delay based on the AV interval and a bundle branch adjustment (BBA) value; measure a QRS characteristic of interest (COI) while utilizing the candidate AV delay in connection with delivering a pacing therapy by the IMD; adjust the BBA value and reset the candidate AV delay based on the BBA value as adjusted; repeat the adjust, reset and measure to obtain a collection of QRS COIs and corresponding candidate AV delays; select one of the candidate AV delays, that corresponds to a select one o

Assignees

Inventors

Classifications

  • Bi-ventricular stimulation · CPC title

  • A61N1/3682Primary

    with a variable atrioventricular delay · CPC title

  • Epicardial electrode systems; Endocardial electrodes piercing the pericardium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11654288B2 cover?
A system and method are provided for managing atrial-ventricular (AV) delay adjustments. An AV interval is measured that corresponds to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event. A candidate AV delay is set based on the AV interval and a bundle branch adjustment (BBA) value. A QRS characteristic of interest (COI) is measure…
Who is the assignee on this patent?
Pacesetter Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/3682. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).